Early Experience of Automated Intraventricular Type Intracranial Pressure Monitoring (LiquoGuard®) for Severe Traumatic Brain Injury Patients.
10.13004/kjnt.2016.12.1.28
- Author:
Young Sub KWON
1
;
Yun Ho LEE
;
Jin Mo CHO
Author Information
1. Department of Neurosurgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Publication Type:Original Article
- Keywords:
Intracranial pressure;
Monitoring, physiologic;
Injections, intraventricular;
Cerebrospinal fluid leak;
Brain injuries
- MeSH:
Brain Injuries*;
Cerebrospinal Fluid;
Drainage;
Humans;
Injections, Intraventricular;
Intracranial Pressure*;
Monitoring, Physiologic
- From:Korean Journal of Neurotrauma
2016;12(1):28-33
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The LiquoGuard® system is a new ventricular-type monitoring device that facilitates intracranial pressure (ICP)-controlled or volume-controlled drainage of cerebrospinal fluid (CSF). The purpose of this study is to report the authors' experience with the LiquoGuard® ICP monitoring system, as well as the clinical safety, usefulness, and limitations of this device in the management of patients with traumatic brain injury (TBI). METHODS: Intraventricular ICP monitoring was performed on 10 patients with TBI using the LiquoGuard® monitoring system. ICP measurements, volume of drained CSF, and clinical outcomes were analyzed and discussed. RESULTS: ICP monitoring was performed on 10 patients for a mean duration of 6.9 days. With a mean 82,718 records per patient, the mean initial ICP was 16.4 mm Hg and the average ICP across the total duration of monitoring was 15.5 mm Hg. The mean volume of drained CSF was 29.2 cc/day, with no CSF drained in 4 patients. Seven of 10 patients showed 1 or 2 episodes of abnormal ICP measurements. No patient exhibited complications associated with ICP monitoring. CONCLUSION: The LiquoGuard® system is a versatile tool in the management of TBI patients. Its use is both reliable and feasible for ICP monitoring and therapeutic drainage of CSF. However, episodes of abnormal ICP measurements were frequently observed in patients with slit ventricles, and further study may be needed to overcome this issue.
